GSK may sell Horlicks to focus on OTC and oral health

The pharmaceuticals firm will take control of Sensodyne and Panadol from joint venture partner Novartis.

Comments

Popular posts from this blog

Newcastle’s transformation and reconnection testament to Howe’s coaching | Andy Brassell

Richarlison’s first Tottenham goals punish Marseille for Mbemba’s red card

Newcastle v Southampton: match preview